QUOIN PHARMACEUTICALS LTD

Historical 13F Holders

Symbol
QNRX
CUSIP
74907L409
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADS
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 74907L409 since 12/18/2024, largest first.

Filer % of Class Filed
Stonepine Capital Management, LLC 13G/A
10.0% 5/15/2026
Event 3/31/2026
Integrated Core Strategies (US) LLC 13G
5.5% 6/2/2026
Event 5/26/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (6)
Resolute Capital Asset Partners LLC 13G
8.5%
Checked 5% or less
12/11/2025
Event 10/10/2025
Armistice Capital, LLC 13G/A
4.99% 5/15/2025
Event 3/31/2025
ADAR1 Capital Management, LLC 13G/A
4.9% 5/15/2026
Event 3/31/2026
Woodline Partners LP 13G/A 4.4% 5/15/2026
Event 3/31/2026
Ikarian Capital, LLC 13G/A
4.4% 10/7/2026
Event 9/30/2026
Aberdeen Group plc 13G/A
4.2% 4/29/2026
Event 4/1/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 1 3.12 k $14.2 k
2026 Q2 19 1.30 M $6.29 M
2026 Q1 21 1.18 M $7.82 M
2025 Q4 18 843 k $12.2 M
2025 Q3 4 1.49 k $10.7 k
2025 Q2 7 2.54 k $23.4 k
2025 Q1 1 108 $24.00